Biofrontera Inc
For the period ended Dec 31, 2023. Filed Mar 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 15, 2024
BFRI$0.89+7.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Woburn, Commonwealth of Massachusetts, on March 15, 2024.
| BIOFRONTERA INC. | |
| By: | /s/ Hermann Lübbert |
| Name: | Hermann Lübbert |
| Title: | Chief Executive Officer and Chairman |
| Signature | Title | Date |
|---|---|---|
| /s/ Hermann Lübbert | Chief Executive Officer and Chairman | March 15, 2024 |
| Hermann Lübbert | (Principal Executive Officer) | |
| /s/ E. Fred Leffler | Chief Financial Officer | March 15, 2024 |
| E. Fred Leffler | (Principal Financial Officer) (Principal Accounting Officer) | |
| /s/ John J. Borer | Director | March 15, 2024 |
| John J. Borer | ||
| /s/ Beth J. Hoffman | Director | March 15, 2024 |
| Beth J. Hoffman | ||
| /s/ Heikki Lanckriet | Director | March 15, 2024 |
| Heikki Lanckriet | ||
| /s/ Kevin D. Weber | Director | March 15, 2024 |
| Kevin D. Weber | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.